Enzo Biochem
527 Madison Ave.
New York
New York
11735-4710
United States
Tel: 212-583-0100
Fax: 212-583-0150
Website: http://www.enzo.com/
Email: info@corp.enzobio.com
364 articles about Enzo Biochem
-
Enzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business Update
3/13/2024
Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the second quarter ended January 31, 2024.
-
Enzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer Appointments
2/1/2024
Enzo Biochem, Inc., a leading life science company, announced the voting results from its Annual Meeting held on January 31, 2024 and officer appointments.
-
ENZO BIOCHEM REPORTS FIRST QUARTER FISCAL 2024 RESULTS AND PROVIDES BUSINESS UPDATE
12/15/2023
Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the first quarter ended October 31, 2023.
-
ENZO BIOCHEM REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 RESULTS AND PROVIDES BUSINESS UPDATE
11/6/2023
Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced financial results for the fourth quarter ended July 31, 2023, and the fiscal year ended July 31, 2023, and also provided a general business update.
-
Steven J. Pully Appointed to Enzo Biochem’s Board of Directors
10/30/2023
Enzo Biochem, Inc., a leading life sciences company, announced that Steven J. Pully has been appointed to the Company’s Board of Directors effective October 26, 2023.
-
Enzo Biochem Announces Departure of Hamid Erfanian and Appointment of Kara Cannon as Interim CEO
9/6/2023
Enzo Biochem, Inc. (NYSE: ENZ) announced today that Hamid Erfanian, Chief Executive Officer (CEO), will be resigning his seat on the Board of Directors and departing the Company effective September 5, 2023, with Enzo’s Chief Operating Officer, Kara Cannon, assuming the role of interim CEO.
-
Enzo Biochem Completes Sale of Clinical Laboratory to Labcorp
7/24/2023
Enzo Biochem, Inc. (NYSE:ENZ) today announced that it has closed a transaction to sell certain assets of Enzo’s Clinical laboratory division (Enzo Clinical Labs) to Laboratory Corporation of America Holdings (Labcorp) (NYSE:LH) pursuant to an Asset Purchase Agreement dated March 16, 2023, as amended July 3, 2023.
-
Enzo Biochem Reports Third Quarter Fiscal Year 2023 Financial Results
6/14/2023
Enzo Biochem, Inc., a pioneering biosciences and diagnostics company, filed its Form 10-Q for the third quarter ended April 30, 2023 of Fiscal Year 2023.
-
Enzo Biochem Reports Significant Progress towards Completing the Clinical Lab Asset Sale
5/22/2023
Enzo Biochem, Inc., announced that the preliminary voting results from the Inspector of Election at today’s Special Meeting of the Shareholders indicate that the Asset Sale Proposal was approved by the affirmative vote of a majority of Enzo’s outstanding common stock.
-
Enzo Biochem, Inc. Announces Date of Special Meeting of Shareholders
4/24/2023
Enzo Biochem, Inc. announced that its special meeting of shareholders to consider and vote on a proposal to approve the sale of substantially all the assets and assignment of certain liabilities of its clinical laboratory business to Labcorp and adopt the Asset Purchase Agreement, dated as of March 16, 2023, by and among the Company, Enzo Clinical Labs, Inc., a New York corporation and Labcorp will be held on May 22, 2023 at 9:00 a.m. Eastern Time.
-
Enzo Biochem Reports Second Quarter Fiscal Year 2023 Financial Results
3/21/2023
Enzo Biochem, Inc. (NYSE:ENZ), a pioneering biosciences and diagnostics company, filed its Form 10-Q for the second quarter ended January 31, 2023 of Fiscal Year 2023.
-
Enzo Biochem Agrees to Sell Clinical Laboratory to Labcorp
3/16/2023
Enzo Biochem, Inc. announced that it has entered into an agreement for Labcorp to acquire the assets of Enzo’s Clinical Laboratory division.
-
Enzo Biochem Reports First Quarter Fiscal Year 2023 Financial Results and Provides Business Update
12/12/2022
Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics company, today reported operating results for the first quarter ended October 31, 2022 of Fiscal Year 2023 (Q1 FY23) and provided a business update on recent corporate and operational developments.
-
Enzo Biochem, Inc. to Report First Quarter Fiscal 2023 Financial Results and Business Update on Monday, December 12th
12/7/2022
Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics company, announced today that it will report first quarter fiscal 2023 financial and operating results after the market close on Monday, December 12, 2022.
-
Enzo Biochem, Inc. Announces Date of Annual Shareholders’ Meeting
11/8/2022
Enzo Biochem, Inc., a leading biosciences and diagnostics company, announced that its Annual Shareholders’ Meeting will be held on January 31, 2023.
-
Enzo Biochem, Inc. Appoints Patricia Eckert, CPA as Interim CFO- David Bench resigning to pursue a new career opportunity -
10/20/2022
Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced the appointment of Patricia Eckert, CPA, as interim Chief Financial Officer (CFO).
-
Enzo Biochem Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Business Update
10/14/2022
Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics company, today reported operating results for the fiscal year and fourth quarter ended July 31, 2022 and provided a business update on recent corporate and operational developments.
-
Enzo Biochem to Report Fourth Quarter 2022 Financial Results and Business Update on Friday, October 14th
10/10/2022
Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics company, announced today that it will report fourth quarter 2022 financial results on Friday, October 14, 2022, premarket.
-
Amgen opened a new research and development site in San Francisco Bay, while Enzo Biochem opened a 100,000 square foot laboratory and research facility in New York
-
Enzo Biochem, Inc. Opens Expanded Life Sciences Laboratory and Office Facilities in Farmingdale, New York
10/6/2022
Enzo Biochem, Inc., a leading biosciences and diagnostics company, announced the official launch of the Company’s new 100,000 square foot state-of-the-art laboratory and research facilities in Farmingdale, New York.